•
Sep 30, 2011

Arrowhead Pharmaceuticals Q4 2011 Earnings Report

Total Revenue
$291M
Previous year: $181K
+160861.6%
EPS
-$0.39
Previous year: -$0.84
-53.6%
Cash and Equivalents
$7.51M
Previous year: $6.85M
+9.6%
Total Assets
$15.9M
Previous year: $12.4M
+28.6%

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals